Q2 2026 Holdings
Filed 2026-08-14 | 77 holdings | $976.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| MBX Biosciences Inc(MBX) | COM | 55287L101 | $44.2M | 800,173 | 4.5% |
| ELI Lilly & Co(LLY) | COM | 532457108 | $42.0M | 35,000 | 4.3% |
| CVS Health Corp(CVS) | COM | 126650100 | $40.5M | 391,791 | 4.1% |
| Dexcom Inc(DXCM) | COM | 252131107 | $36.0M | 534,767 | 3.7% |
| PTC Therapeutics Inc(PTCT) | COM | 69366J200 | $35.5M | 435,691 | 3.6% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $28.3M | 919,266 | 2.9% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $26.1M | 485,661 | 2.7% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $25.3M | 1,377,576 | 2.6% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $24.8M | 669,046 | 2.5% |
| Inhibrx Biosciences Inc(INBX) | COM | 45720N103 | $24.3M | 256,950 | 2.5% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $24.0M | 397,379 | 2.5% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $23.4M | 577,036 | 2.4% |
| Unitedhealth Group Inc(UNH) | COM | 91324P102 | $23.2M | 55,921 | 2.4% |
| Stryker Corporation(SYK) | COM | 863667101 | $21.4M | 67,973 | 2.2% |
| Iqvia Hldgs Inc(IQV) | COM | 46266C105 | $20.4M | 105,811 | 2.1% |
| Zimmer Biomet Holdings Inc(ZBH) | COM | 98956P102 | $20.0M | 232,557 | 2.0% |
| Insulet Corp(PODD) | COM | 45784P101 | $20.0M | 131,378 | 2.0% |
| Assembly Biosciences Inc(ASMB) | COM NEW | 045396207 | $19.8M | 721,181 | 2.0% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $19.2M | 877,256 | 2.0% |
| Eyepoint Inc(EYPT) | COM NEW | 30233G209 | $18.4M | 1,288,163 | 1.9% |
| Tenet Healthcare Corp(THC) | COM NEW | 88033G407 | $18.2M | 97,280 | 1.9% |
| Livanova PLC(LIVN) | SHS | G5509L101 | $17.3M | 210,529 | 1.8% |
| ANI Pharmaceuticals Inc(ANIP) | COM | 00182C103 | $16.8M | 202,907 | 1.7% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $16.2M | 1,624,279 | 1.7% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $15.3M | 50,672 | 1.6% |
| Indivior Pharmaceuticals Inc(INDV) | COM | 45579U109 | $14.9M | 364,269 | 1.5% |
| Envista Holdings Corporation(NVST) | COM | 29415F104 | $14.6M | 553,916 | 1.5% |
| Bright Minds Biosciences Inc(DRUG) | COM NEW | 10919W405 | $14.4M | 205,053 | 1.5% |
| Xeris Biopharma Holdings Inc(XERS) | COM | 98422E103 | $14.3M | 1,807,621 | 1.5% |
| Avalo Therapeutics Inc(AVTX) | COM NEW | 05338F306 | $14.2M | 766,290 | 1.4% |
| 4D Molecular Therapeutics in(FDMT) | COM | 35104E100 | $12.6M | 948,184 | 1.3% |
| Immunome Inc(IMNM) | COM | 45257U108 | $12.6M | 594,202 | 1.3% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $11.6M | 355,443 | 1.2% |
| Waters Corp(WAT) | COM | 941848103 | $11.3M | 30,206 | 1.2% |
| Alto Neuroscience Inc(ANRO) | COM SHS | 02157Q109 | $11.3M | 429,035 | 1.2% |
| Oruka Therapeutics Inc(ORKA) | COM | 687604108 | $10.8M | 113,188 | 1.1% |
| Adaptive Biotechnologies COR(ADPT) | COM | 00650F109 | $10.4M | 486,984 | 1.1% |
| Absci Corporation(ABSI) | COM | 00091E109 | $10.4M | 894,374 | 1.1% |
| Mineralys Therapeutics Inc(MLYS) | COM | 603170101 | $10.3M | 380,354 | 1.1% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $9.8M | 253,365 | 1.0% |
| Uniqure NV(QURE) | SHS | N90064101 | $9.6M | 208,170 | 1.0% |
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $9.4M | 150,000 | 1.0% |
| Amneal Pharmaceuticals Inc(AMRX) | COM STK CL A | 03168L105 | $9.4M | 541,190 | 1.0% |
| Irhythm Holdings Inc(IRTC) | COM | 450056106 | $8.0M | 67,267 | 0.8% |
| Cryoport Inc(CYRX) | COM PAR $0.001 | 229050307 | $8.0M | 508,324 | 0.8% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $7.7M | 180,481 | 0.8% |
| Climb BIO Inc(CLYM) | COM | 28658R106 | $7.3M | 563,484 | 0.8% |
| Amylyx Pharmaceuticals Inc(AMLX) | COM | 03237H101 | $7.2M | 398,782 | 0.7% |
| Upstream BIO Inc(UPB) | COM | 91678A107 | $6.5M | 935,247 | 0.7% |
| Resmed Inc(RMD) | COM | 761152107 | $6.4M | 32,983 | 0.7% |